Safety Evaluation of Therapeutic Interventions for Plantar Warts (Kapasi): Psychodermatology, Stress-Mediated Immunity, and Regulatory Considerations
Authors
DOI:
https://doi.org/10.55121/fds.v3i2.976Abstract
Currently, there are more than 3 million people worldwide suffering from plantar warts (Kapsi). Possible ways of treatment include keratolytics, cryosurgery, lasers, and intralesional immunotherapy. However, many factors, including the high rate of treatment failure, local regulations, safety concerns, and self-medicating practices, complicate these methods. Some studies indicate that psychosocial stress may worsen the effect of therapy in the case of viral infections by decreasing immune function via the action of cortisol, thus contributing to increased susceptibility to HPV (Human Papillomavirus) infection and persistent lesions. Nevertheless, despite all these observations, the role of psychology in drug therapy remains underestimated in this area. This literature review integrates the perspectives of dermatologists, immunologists, psychoneuroendocrinologists, and specialists in pharmacovigilance. The analysis focuses on currently popular treatments, including nitric oxide patches, vitamin D3 injections, immunization based on the MMR vaccine, nanoparticle-based drugs, as well as off-label use of various acids, among others. Special attention is paid to the potential toxicity, safety, efficiency, regulatory approval, and risks of self-treatment. In addition, issues of chemical burns from uncontrolled wart medications, the need to improve post-marketing monitoring of safety, and the danger of HPV infection associated with laser treatment are covered. Some of the key gaps related to plantar wart treatment include a lack of psychodermatology protocols for managing patients with mental stress, inadequate prediction of the effectiveness of treatment in such cases, different OTC treatment regulations, and insufficient knowledge concerning the risks associated with immunotherapies. Possible future improvements include better regulation of medications, novel and safe treatments, and the development of artificial intelligence monitoring and adaptation systems.
Keywords
Plantar Warts, Drug Safety, Stress–Immunity, HPV, PsychodermatologyReferences
[1] Sterling, J.C., Gibbs, S., Haque Hussain, S.S., et al., 2014. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. British Journal of Dermatology. 171(4), 696–712. DOI: https://doi.org/10.1111/bjd.13310
[2] Arndt, J., Smith, N., Tausk, F., 2008. Stress and atopic dermatitis. Current Allergy and Asthma Reports. 8(4), 312–317. DOI: https://doi.org/10.1007/s11882-008-0050-6
[3] Boyle, J., 2008. Molecular biology of the cell, 5th edition by B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter. Biochemistry and Molecular Biology Education. 36(4), 317–318. DOI: https://doi.org/10.1002/bmb.20192
[4] Bunney, M.H., Nolan, M.W., Williams, D.A., 1976. An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. British Journal of Dermatology. 94(6), 667–679. DOI: https://doi.org/10.1111/j.1365-2133.1976.tb05167.x
[5] Cockayne, S., Hewitt, C., Hicks, K., et al., 2011. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): A randomised controlled trial. BMJ. 342, d3271–d3271. DOI: https://doi.org/10.1136/bmj.d3271
[6] Bruggink, S.C., Gussekloo, J., Berger, M.Y., et al., 2010. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. Canadian Medical Association Journal. 182(15), 1624–1630. DOI: https://doi.org/10.1503/cmaj.092194
[7] DermNet New Zealand, n.d. The world's leading free dermatology website. Available from: https://dermnetnz.org (cited 20 October 2025).
[8] Redzic, N., Benoy, I., Vanden Broeck, D., et al., 2021. Development and validation of a wart‐associated human papilloma virus genotyping assay for detection of HPV in cutaneous warts. Journal of Medical Virology. 93(6), 3841–3848. DOI: https://doi.org/10.1002/jmv.26623
[9] Bruggink, S.C., De Koning, M.N.C., Gussekloo, J., et al., 2012. Cutaneous wart-associated HPV types: Prevalence and relation with patient characteristics. Journal of Clinical Virology. 55(3), 250–255. DOI: https://doi.org/10.1016/j.jcv.2012.07.014
[10] Villares, M., Berthelet, J., Weitzman, J.B., 2020. The clever strategies used by intracellular parasites to hijack host gene expression. Seminars in Immunopathology. 42(2), 215–226. DOI: https://doi.org/10.1007/s00281-020-00779-z
[11] Hogendoorn, G.K., Bruggink, S.C., De Koning, M.N.C., et al., 2018. Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous warts. British Journal of Dermatology. 178(1), 253–260. DOI: https://doi.org/10.1111/bjd.15758
[12] Glaser, R., Kiecolt-Glaser, J.K., 2005. Stress-induced immune dysfunction: Implications for health. Nature Reviews Immunology. 5(3), 243–251. DOI: https://doi.org/10.1038/nri1571
[13] Arck, P.C., Slominski, A., Theoharides, T.C., et al., 2006. Neuroimmunology of Stress: Skin Takes Center Stage. Journal of Investigative Dermatology. 126(8), 1697–1704. DOI: https://doi.org/10.1038/sj.jid.5700104
[14] Garg, A., Chren, M.-M., Sands, L.P., et al., 2001. Psychological Stress Perturbs Epidermal Permeability Barrier Homeostasis: Implications for the Pathogenesis of Stress-Associated Skin Disorders. Archives of Dermatology. 137(1). DOI: https://doi.org/10.1001/archderm.137.1.53
[15] Kwok, C.S., Gibbs, S., Bennett, C., et al., 2012. Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews. 2020(12). DOI: https://doi.org/10.1002/14651858.CD001781.pub3
[16] Connolly, M., Bazmi, K., O’Connell, M., et al., 2001. Cryotherapy of viral warts: A sustained 10-s freeze is more effective than the traditional method. British Journal of Dermatology. 145(4), 554–557. DOI: https://doi.org/10.1046/j.1365-2133.2001.04449.x
[17] Cengiz, F.P., Emiroglu, N., Su, O., et al., 2016. Effectiveness and safety profile of 40% trichloroacetic acid and cryotherapy for plantar warts. The Journal of Dermatology. 43(9), 1059–1061. DOI: https://doi.org/10.1111/1346-8138.13370
[18] Clifton, M.M., Johnson, S.M., Roberson, P.K., et al., 2003. Immunotherapy for Recalcitrant Warts in Children Using Intralesional Mumps or Candida Antigens. Pediatric Dermatology. 20(3), 268–271. DOI: https://doi.org/10.1046/j.1525-1470.2003.20318.x
[19] Garden, J.M., 1988. Papillomavirus in the Vapor of Carbon Dioxide Laser-Treated Verrucae. JAMA: The Journal of the American Medical Association. 259(8), 1199. DOI: https://doi.org/10.1001/jama.1988.03720080033024
[20] Awal, G., Kaur, S., 2018. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial. The Journal of Clinical and Aesthetic Dermatology. 11(5), 15–20. Available from: https://pubmed.ncbi.nlm.nih.gov/29785233/
[21] Bennardo, L., Fasano, G., Tamburi, F., et al., 2022. Sequential Use of CO2 Laser Prior to Nd: YAG and Dye Laser in the Management of Non-Facial Warts: A Retrospective Study. Medicina. 58(1), 115. DOI: https://doi.org/10.3390/medicina58010115
[22] Schumacher, S.A., Dugom, L., Martins, J., et al., 2026. Efficacy and safety of a topical nitric oxide–releasing solution (NORS) as a noninvasive treatment for plantar warts (verrucae plantaris). Journal of Dermatological Treatment. 37(1), 2610918. DOI: https://doi.org/10.1080/09546634.2025.2610918
[23] Youn, S.H., Kwon, I.H., Park, E.J., et al., 2011. A Two-week Interval Is Better Than a Three-week Interval for Reducing the Recurrence Rate of Hand-foot Viral Warts after Cryotherapy: A Retrospective Review of 560 Hand-foot Viral Warts Patients. Annals of Dermatology. 23(1), 53. DOI: https://doi.org/10.5021/ad.2011.23.1.53
[24] Bruggink, S.C., Eekhof, J.A.H., Egberts, P.F., et al., 2013. Warts Transmitted in Families and Schools: A Prospective Cohort. Pediatrics. 131(5), 928–934. DOI: https://doi.org/10.1542/peds.2012-2946
[25] Ciconte, A., Campbell, J., Tabrizi, S., et al., 2003. Warts are not merely blemishes on the skin: A study on the morbidity associated with having viral cutaneous warts. Australasian Journal of Dermatology. 44(3), 169–173. DOI: https://doi.org/10.1046/j.1440-0960.2003.00672.x
[26] U.S. Food and Drug Administration, 1990. Salicylic Acid Drug Products for Over-The-Counter Human Use. U.S. Food and Drug Administration: Silver Spring, MD, USA.
[27] Nofal, A., Nofal, E., 2010. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. Journal of the European Academy of Dermatology and Venereology. 24(10), 1166–1170. DOI: https://doi.org/10.1111/j.1468-3083.2010.03611.x
[28] Hazell, L., Shakir, S.A.W., 2006. Under-Reporting of Adverse Drug Reactions: A Systematic Review. Drug Safety. 29(5), 385–396. DOI: https://doi.org/10.2165/00002018-200629050-00003
[29] Gupta, M.A., Gupta, A.K., 1996. Psychodermatology: An update. Journal of the American Academy of Dermatology. 34(6), 1030–1046. DOI: https://doi.org/10.1016/S0190-9622(96)90284-4
[30] Richards, H., Fortune, D., Griffiths, C., 2006. Adherence to treatment in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. 20(4), 370–379. DOI: https://doi.org/10.1111/j.1468-3083.2006.01565.x
[31] Bower, J.E., Irwin, M.R., 2016. Mind–body therapies and control of inflammatory biology: A descriptive review. Brain, Behavior, and Immunity. 51, 1–11. DOI: https://doi.org/10.1016/j.bbi.2015.06.012
[32] Du‐Harpur, X., Watt, F.M., Luscombe, N.M., et al., 2020. What is AI? Applications of artificial intelligence to dermatology. British Journal of Dermatology. 183(3), 423–430. DOI: https://doi.org/10.1111/bjd.18880
[33] Pondeljak, N., Lugović-Mihić, L., 2020. Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters. Clinical Therapeutics. 42(5), 757–770. DOI: https://doi.org/10.1016/j.clinthera.2020.03.008
[34] Wiktorowicz, M., Lexchin, J., Moscou, K., 2012. Pharmacovigilance in Europe and North America: Divergent approaches. Social Science & Medicine. 75(1), 165–170. DOI: https://doi.org/10.1016/j.socscimed.2011.11.046
Downloads
How to Cite
Copyright & License
Copyright (c) 2026 Sarah Gadavala , Sheetal Sandip Buddhadev, Sandip Buddhadev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submit Manuscript
